90 related articles for article (PubMed ID: 26763434)
1. Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression.
Nakahara T; Oba J; Shimomura C; Kido-Nakahara M; Furue M
J Invest Dermatol; 2016 Jan; 136(1):146-53. PubMed ID: 26763434
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.
Norian LA; Rodriguez PC; O'Mara LA; Zabaleta J; Ochoa AC; Cella M; Allen PM
Cancer Res; 2009 Apr; 69(7):3086-94. PubMed ID: 19293186
[TBL] [Abstract][Full Text] [Related]
3. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
[TBL] [Abstract][Full Text] [Related]
4. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
[TBL] [Abstract][Full Text] [Related]
5. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
Pietra G; Mortarini R; Parmiani G; Anichini A
Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
[TBL] [Abstract][Full Text] [Related]
6. [Bioimmunological characteristics of mature or immature murine dendritic cells].
Wang KL; Guo L; Shi RF; Wang JL; Dong SH
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3225-8. PubMed ID: 22333110
[TBL] [Abstract][Full Text] [Related]
7. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V
Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.
Roux S; Apetoh L; Chalmin F; Ladoire S; Mignot G; Puig PE; Lauvau G; Zitvogel L; Martin F; Chauffert B; Yagita H; Solary E; Ghiringhelli F
J Clin Invest; 2008 Nov; 118(11):3751-61. PubMed ID: 18830416
[TBL] [Abstract][Full Text] [Related]
11. [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice].
Shi L; Chen J; Zhong Q; Geng P; He J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):177-82. PubMed ID: 24785276
[TBL] [Abstract][Full Text] [Related]
12. Murine corneal stroma cells suppress bone marrow-derived dendritic cells maturation in vitro.
Lu JM; Jiang XL; Liu JL; Wang HF; Li XL; Song XJ
Chin Med J (Engl); 2012 Jun; 125(11):2041-7. PubMed ID: 22884074
[TBL] [Abstract][Full Text] [Related]
13. Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma.
Jia J; Wang Z; Li X; Wang Z; Wang X
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):223-7. PubMed ID: 22142817
[TBL] [Abstract][Full Text] [Related]
14. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma S; Stolina M; Yang SC; Baratelli F; Lin JF; Atianzar K; Luo J; Zhu L; Lin Y; Huang M; Dohadwala M; Batra RK; Dubinett SM
Clin Cancer Res; 2003 Mar; 9(3):961-8. PubMed ID: 12631593
[TBL] [Abstract][Full Text] [Related]
15. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
16. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells.
Takagi Y; Kikuchi T; Niimura M; Ohno T
Cancer Lett; 2004 Sep; 213(1):49-55. PubMed ID: 15312683
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
20. Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.
Gatti G; Nuñez NG; Nocera DA; Dejager L; Libert C; Giraudo C; Maccioni M
Eur J Immunol; 2013 Jul; 43(7):1849-61. PubMed ID: 23636788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
